ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

IMRN Immuron Ltd

2.52
-0.02 (-0.79%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Immuron Ltd IMRN NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
-0.02 -0.79% 2.52 13:00:11
始値 安値 高値 終値 前日終値
2.62 2.4815 2.62 2.52 2.54
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0319:00GLOBEImmuron Director Resignation
2024/4/1519:00GLOBEImmuron to host Live Virtual Event
2024/4/1019:00GLOBEImmuron Travelan® sales continued strong growth
2024/3/0722:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0720:00GLOBEImmuron Announces Positive Results Support Travelan®..
2024/2/2822:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2122:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2120:00GLOBEImmuron Presentation Australian Biologics Festival 2024
2024/2/1322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1320:00GLOBEImmuron achieves record Travelan® sales
2024/2/0820:00GLOBEImmuron CEO, Steven Lydeamore Investor Webinar Presentation
2024/1/1622:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1620:00GLOBEImmuron achieves record half yearly Travelan® sales
2023/12/2221:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2220:00GLOBEImmuron Clinical Trials Update
2023/12/0420:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0420:00GLOBEImmuron Announces First Patients Enrolled in Campylobacter..
2023/11/2820:33GLOBEImmuron CEO, Steven Lydeamore Investor Webinar Presentation
2023/11/2820:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2221:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2120:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1408:00GLOBEImmuron CEO Steven Lydeamore Investor Webinar Presentation
2023/11/1322:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/3021:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/3020:21GLOBEImmuron CEO Steven Lydeamore presented at AusBioInvest
2023/10/2321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1819:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1819:00GLOBEImmuron Announces Travelan® Clinical Study Cohort 2..
2023/10/1119:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1119:00GLOBEImmuron achieves record quarterly Travelan® sales
2023/9/2821:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2819:18EDGAR2Form 20-F - Annual and transition report of foreign private..
2023/9/1319:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1319:00GLOBEImmuron achieves record monthly Travelan® sales
2023/9/1119:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1119:00GLOBEImmuron CEO, Steven Lydeamore to present at H.C. Wainwright
2023/8/3019:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1419:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1419:00GLOBEImmuron to present at the Military Health System Research..
2023/8/0919:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2519:00GLOBEImmuron Announces First Patients Enrolled in Travelan®..
2023/7/2510:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2419:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2419:00GLOBEImmuron CEO, Steven Lydeamore to present at Bioshares
2023/7/1119:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1119:00GLOBEImmuron Business Update - Ateria Health launches Juvia™ in..
2023/7/0519:00GLOBEImmuron FY23 Sales increase 136% on FY22 Sales
2023/6/3019:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/6/3019:00GLOBEImmuron Chairman Transition
2023/6/2219:00GLOBEImmuron Business Update: Letter to Shareholders

最近閲覧した銘柄

Delayed Upgrade Clock